Amneal Pharmaceuticals Class A financial statements
엠닐 파머슈티컬스NASDAQ:AMRX · Nasdaq · Healthcare$20.30+1.15%
2026-10-02 closeAmneal Pharmaceuticals Class A's published financial data is dated 2026-10-04. 2024 revenue was $2.79B. 2024 operating profit was $249M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy